Drugs / [68Ga]Ga DOTA-5G

Trials 1

20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07020806 Nov 2025 → Jun 2027 expected breast lobular carcinoma University of California, Davis Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as [68Ga]Ga DOTA-5G ClinicalTrials.gov intervention name — accepted as the source's own label NCT07020806 ↗
Modality Diagnostic / imaging agent “Diagnostic Imaging Agent” NCT07020806 ↗